PW Medtech Group Limited (HKG:1358)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9100
-0.0200 (-2.15%)
Oct 2, 2026, 3:23 PM HKT

PW Medtech Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
803.19823.51768.9675.08536.83271.4
Revenue Growth
-4.93%7.10%13.90%25.75%97.80%9.72%
Cost of Revenue
418.61416.05349.46294.19238105.34
Gross Profit
384.58407.46419.45380.9298.83166.06
Selling, General & Admin
277.66268.86243.55195.11189.57123.09
Research & Development
51.6248.4144.1241.1340.9820.25
Other Operating Expenses
-25.96-29.02-39.2-34.48-29.89-24.35
Operating Expenses
298.62281.75245.8201.76200.66118.99
Operating Income
85.96125.71173.65179.1498.1747.07
Interest Expense
-0.78-0.72-0.37-0.15-0.46-0.61
Interest & Investment Income
36.2744.550.6543.8335.3757.34
Currency Exchange Gain (Loss)
-12.43-6.887.53.4930.47-40.88
Other Non Operating Income (Expenses)
0.94-0.94----
EBT Excluding Unusual Items
109.96161.67231.42226.3163.5462.92
Merger & Restructuring Charges
-----4.8-3.92
Gain (Loss) on Sale of Investments
5.155.950.36---
Gain (Loss) on Sale of Assets
-0.05-0.07-0.11-7.14-0.01731.79
Asset Writedown
-1.63-1.82-1.18-0.06-0.25-52.59
Legal Settlements
-0.73-0.73-0.73-0.73-0.73-0.73
Other Unusual Items
---12.7--
Pretax Income
112.7164.99229.75231.07157.75737.46
Income Tax Expense
26.3929.7437.2326.0428.88-1.65
Earnings From Continuing Operations
86.32135.25192.52205.02128.87739.12
Net Income to Company
86.32135.25192.52205.02128.87739.12
Minority Interest in Earnings
-43.25-40.88-41.74-51.84-22.830
Net Income
43.0794.37150.78153.18106.04739.12
Net Income to Common
43.0794.37150.78153.18106.04739.12
Net Income Growth
-70.62%-37.41%-1.57%44.46%-85.65%16.98%
Shares Outstanding (Basic)
1,4971,5111,5431,5661,5661,569
Shares Outstanding (Diluted)
1,4971,5111,5431,5661,5661,569
Shares Change
-0.47%-2.11%-1.42%-0.03%-0.20%-0.00%
EPS (Basic)
0.030.060.100.100.070.47
EPS (Diluted)
0.030.060.100.100.070.47
EPS Growth
-70.47%-36.06%-0.11%44.46%-85.63%16.99%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
154.48150.66261.93163.73216.7725.92
Free Cash Flow Per Share
0.100.100.170.100.140.02
Dividend Per Share
0.0270.0580.0920.089--
Dividend Growth
-70.25%-37.55%3.00%---
Gross Margin
47.88%49.48%54.55%56.42%55.66%61.19%
Operating Margin
10.70%15.27%22.58%26.54%18.29%17.34%
Profit Margin
5.36%11.46%19.61%22.69%19.75%272.34%
Free Cash Flow Margin
19.23%18.30%34.06%24.25%40.38%9.55%
EBITDA
227.97262.86288.92276.11175.4977.98
EBITDA Margin
28.38%31.92%37.58%40.90%32.69%28.73%
D&A For EBITDA
142.01137.15115.2896.9777.3230.91
EBIT
85.96125.71173.65179.1498.1747.07
EBIT Margin
10.70%15.27%22.58%26.54%18.29%17.34%
Effective Tax Rate
23.41%18.03%16.20%11.27%18.31%-